LIMINATUS PHARMA, INC. (LIMN) Operating income 2024–2025
LIMINATUS PHARMA, INC. (LIMN) annual operating income history from SEC filings — each fiscal year as reported.
-$3.0MFY2025 · since FY2024: -$3.3M → -$3.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.0M | +10.9% |
| FY2024 | -$3.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LIMN financial trends
LIMN RevenueLIMN Net incomeLIMN Net marginLIMN Gross profitLIMN Gross marginLIMN Operating marginLIMN Operating cash flowLIMN Free cash flowLIMN Capital expendituresLIMN Return on equityLIMN Stock buybacksLIMN Dividends paidLIMN Total assetsLIMN Total liabilitiesLIMN Shareholders’ equityLIMN overview →